Raymond James & Associates Has $1.69 Million Position in Option Care Health, Inc. (NASDAQ:OPCH)

Raymond James & Associates raised its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 200.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 50,047 shares of the company’s stock after buying an additional 33,414 shares during the period. Raymond James & Associates’ holdings in Option Care Health were worth $1,686,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of OPCH. Vontobel Holding Ltd. lifted its stake in shares of Option Care Health by 2.9% in the 3rd quarter. Vontobel Holding Ltd. now owns 13,168 shares of the company’s stock valued at $426,000 after purchasing an additional 374 shares during the last quarter. IHT Wealth Management LLC lifted its stake in shares of Option Care Health by 4.7% in the 3rd quarter. IHT Wealth Management LLC now owns 9,352 shares of the company’s stock valued at $294,000 after purchasing an additional 419 shares during the last quarter. Securian Asset Management Inc. lifted its stake in shares of Option Care Health by 3.4% in the 3rd quarter. Securian Asset Management Inc. now owns 15,235 shares of the company’s stock valued at $493,000 after purchasing an additional 503 shares during the last quarter. Sheets Smith Wealth Management lifted its stake in shares of Option Care Health by 1.6% in the 3rd quarter. Sheets Smith Wealth Management now owns 32,542 shares of the company’s stock valued at $1,053,000 after purchasing an additional 510 shares during the last quarter. Finally, Public Employees Retirement System of Ohio lifted its stake in shares of Option Care Health by 39.1% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 2,236 shares of the company’s stock valued at $70,000 after purchasing an additional 629 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the company’s stock in a transaction dated Monday, February 26th. The shares were bought at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the acquisition, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH opened at $30.27 on Thursday. The company has a market capitalization of $5.26 billion, a PE ratio of 20.59, a price-to-earnings-growth ratio of 1.76 and a beta of 1.22. Option Care Health, Inc. has a one year low of $24.23 and a one year high of $35.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.33. The company’s fifty day moving average price is $32.34 and its 200 day moving average price is $31.59.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Thursday, February 22nd. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.09 billion. Option Care Health had a net margin of 6.21% and a return on equity of 18.78%. The business’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.26 EPS. As a group, analysts expect that Option Care Health, Inc. will post 1.13 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on OPCH shares. Jefferies Financial Group lifted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th. Barrington Research lifted their target price on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “outperform” rating in a report on Friday, February 23rd.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.